| Patents for C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111) |
|---|
| 02/08/2006 | CN1240709C Herminium's triochistisaponine extract and its extraction refining method and its medical use |
| 02/01/2006 | CN1239161C Method for treating dry eye disorders |
| 01/19/2006 | US20060014704 Compounds and their preparation for the treatment of Alzheimer's disease by inhibiting beta-amyloid peptide production |
| 01/18/2006 | CN1237071C Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 01/12/2006 | US20060009431 Nitrosated and nitrosylated compounds, compositions and methods use |
| 01/11/2006 | EP1104306B1 Compositions of cpg and saponin adjuvants and methods of use thereof |
| 01/05/2006 | WO2004028475A3 Glycosylceramide analogues |
| 01/04/2006 | CN1717414A Promoter for the production of hyaluronic acid containing ginsenoside compound K |
| 12/14/2005 | EP1603933A2 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 12/14/2005 | CN1706862A Pseudoginsenoside Pdq and its semi-synthesis process and medicine use |
| 12/08/2005 | WO2005116049A1 Selective separation or extraction of steroidal glycosides by supercritical fluid extraction using carbon dioxide |
| 12/08/2005 | WO2005116042A1 Treatment and prevention of cancer with new ginsenoside derivatives |
| 12/01/2005 | US20050267051 Antineoplastic and anti-HIV conjugates of steroid acid and nucleosides |
| 11/29/2005 | CA2123048C Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments |
| 11/23/2005 | EP1598054A2 Method of suppressing appetite |
| 11/23/2005 | CN1228441C Prevotella Shan and Collins S-1 and process for prepn. of metabolites of ginseng saponins |
| 11/09/2005 | CN1226303C High yield separating method for ginseng saponin Rb1 |
| 11/03/2005 | US20050245465 Compounds for treating Alzheimer's disease and for inhibiting beta-amyloid peptitde production |
| 10/28/2005 | WO2006124012A2 Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production |
| 10/28/2005 | CA2565002A1 Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptide production |
| 10/18/2005 | US6956031 Therapy for estrogen sensitive disease; anticancer agents |
| 10/13/2005 | WO2005095436A1 Glycoside having 4-methylergost-7-en-3-ol skeleton and drug for ameliorating hyperglycemia |
| 10/12/2005 | CN1681514A A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 10/12/2005 | CN1680425A 6.alpha., 9.alpha.-difluoro-17.alpha.-'(2-furanylcaboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1, 4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflamatory agent |
| 10/12/2005 | CN1680423A Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 09/27/2005 | US6949533 use in treating asthma, allergy, arthritis and thrombosis |
| 09/27/2005 | US6949523 Anticancer agents |
| 09/22/2005 | US20050209445 Using solvent extraction to isolate saponins from aquatic plants |
| 09/22/2005 | US20050209206 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 09/22/2005 | US20050209168 Isolation of tigogenin pentaglycoside from chlorophytum nimonii |
| 09/21/2005 | EP1575982A1 Promoter for the production of hyaluronic acid containing ginsenoside compound k |
| 09/15/2005 | WO2005084689A1 Radix astragli extract and production method and use thereof |
| 09/14/2005 | EP1572114A2 Glycosylceramide analogues |
| 09/07/2005 | EP1569951A2 Novel crystalline complexes |
| 09/07/2005 | CN1665831A Novel compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 08/31/2005 | CN1660167A Effective part of astragalus, preparing method and application in pharmacy |
| 08/31/2005 | CN1216895C Rhizoma alsmatis total triterpene alcohol extract and its preparation method |
| 08/17/2005 | EP1562627A2 Corticosteroid conjugates and uses thereof |
| 08/11/2005 | US20050175623 Plant extracts from such as quillaja saponaria molina; potentiators and chemotherapeautics |
| 08/10/2005 | CN1214038C 9alpha-chloro-6alpha-fluoro-17alpha-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl proup |
| 08/03/2005 | EP1175433B1 Androgen glycosides and androgenic activity thereof |
| 07/28/2005 | US20050164997 a 3-oxo-androstancarbothioic acid compound; respiaratory system disorder |
| 07/26/2005 | US6921757 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 07/21/2005 | US20050158727 Derivatized oligonucleotides having improved uptake and other properties |
| 07/14/2005 | WO2004024745A3 Complexes of 6.alpha. 9.alpha. - difluoro - 17. alpha. - [ (2 - furanylcarbonyl) oxy] - 11.beta. -hydroxy - 16- .alpha. -methyl - 3oxo- androsta- 1,4 -diene - 17 .beta. -carbothioic acid s-fluoromethyl ester |
| 07/14/2005 | US20050152845 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form |
| 07/13/2005 | EP1551865A2 Hybrid molcules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 07/12/2005 | US6916791 Androgen glycosides useful as contraceptives, for increasing muscle mass, and treatment of a hypogonadal disorder, androgen deficiency, sexual dysfunction and osteoporosis |
| 07/06/2005 | CN1634970A Process for preparing notoginsen triterpenes |
| 07/05/2005 | CA2118928C Saponin-antigen conjugates and the use thereof |
| 06/28/2005 | CA2138839C Sialic acid derivatives |
| 06/23/2005 | US20050136003 Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use |
| 06/22/2005 | CN1630528A Brain cell or nerve cell protecting agents comprising ginseng |
| 06/16/2005 | WO2004017904A3 Corticosteroid conjugates and uses thereof |
| 06/16/2005 | US20050130947 6alpha, 9alpha-Difluoro-17alpha-((2-furanylcarbonyl)oxy)-11beta-hydroxy-16alpha-methyl-3-oxo-androsta-1,4-diene-17beta-carbothioic acid S-fluoromethyl ester completely dissolved in a liquified hydrofluoroalkane (HFA) gas as propellant; for asthma or chronic obstructive pulmonary disease (COPD) |
| 06/15/2005 | EP1539796A1 Anti-inflammatory or anti-allergic androstane complexes |
| 06/01/2005 | CN1203861C Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |
| 05/26/2005 | US20050113316 Process for producing dammarane sapogenins and ginsenosides |
| 05/24/2005 | US6897298 Method for extracting a compound from a ginseng spp. plant, ginseng or pseudo-ginseng |
| 05/12/2005 | WO2005042033A1 Novel chemical agents comprising a cardiotonic moiety and an imaging moiety and methods of their use |
| 05/11/2005 | CN1613866A Preparation of gynostemma pentaphylla saponin |
| 05/06/2005 | WO2005040189A1 Novel dammarane sapogenins and their use as anti-cancer agents |
| 05/04/2005 | CN1611510A Process for extracting saponin from pseudo-ginseng stem-leaf-flower |
| 05/03/2005 | US6888014 Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | US20050085427 Transfection agents |
| 04/12/2005 | US6878698 Anti-inflammatory androstane derivatives |
| 04/06/2005 | EP1299409B1 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/06/2005 | CN1603335A Process for preparing notoginseng triol saponin |
| 04/06/2005 | CN1603334A Process for preparing notoginseng diol saponin |
| 03/31/2005 | WO2004098538A3 Nitrosated and nitrosylated compounds, compositions and methods of use |
| 03/31/2005 | US20050070515 Glucocorticosteroids which are hydrolysable in human or animal blood by lactonase enzyme; for treatment of respiratory and gastrointestinal disorders; side effect reduction |
| 03/16/2005 | EP1513862A2 Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 03/16/2005 | EP1135134B1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases |
| 03/16/2005 | CN1594352A Process for separating diol ginsenoside and triol ginsenoside |
| 03/16/2005 | CN1193037C Ginsenoside acid hydrolyzing process of preparing protopanoxadiol |
| 03/10/2005 | US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
| 03/10/2005 | US20050053955 Nucleic acid-based assay and kit for the detection of methanogens in biological samples |
| 02/24/2005 | US20050043284 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 02/24/2005 | US20050043219 Derivatized oligonucleotides having improved uptake and other properties |
| 02/22/2005 | US6858596 Aqueous suspension of Fluticasone furoate; respiratory tract disorders; asthma, COPD; antiinflammatory, antiallergen; nasal inhaler |
| 02/22/2005 | US6858593 Composition in which the crystal lattice is stabilised by the presence of a guest molecule, characterised in the crystalline composition is of space group P212121 having unit cell dimensions of about 7. 6+-0.6 Angstrom , 12.7+-0.7 Angstrom , |
| 02/17/2005 | WO2004092329A3 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines |
| 02/03/2005 | US20050026888 Formulation containing anti-inflammatory androstane derivatives |
| 02/02/2005 | CN1187364C 类固醇衍生物 Steroid derivatives |
| 01/27/2005 | WO2005007172A1 Glycoside-containing liposome |
| 01/27/2005 | US20050020549 aqueous suspension; rhinitis therapy |
| 01/27/2005 | US20050020480 Administering a steroid |
| 01/05/2005 | CN1560069A Process for extracting total flavone and total oside of astragalus from astragalus |
| 01/05/2005 | CN1183154C Solid dispersion containing sialic acid derivative |
| 12/28/2004 | US6835724 Corticoid 17,21-dicarboxylic esters and corticosteroid 17-carboxylic ester 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds |
| 12/16/2004 | CA2528136A1 Transfection agents |
| 12/15/2004 | EP0837874B1 Neuroactive steroids of the androstane and pregnane series |
| 12/14/2004 | US6831166 Derivatized oligonucleotides having improved uptake and other properties |
| 12/09/2004 | US20040248867 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/08/2004 | EP1482950A1 A method of treating diabetes mellitus including conditions associated with diabetes mellitus and complications of diabetes mellitus |
| 12/08/2004 | CN1553918A Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same |
| 12/02/2004 | US20040242502 Semi-synthetic saponin analogs with carrier and immune stimulatory activities for DNA and RNA vaccines |
| 12/02/2004 | US20040241858 Diagnosing cardiovascular and/or antiphospholipid disorders via presence of cholesterol/beta glycoprotein complexes in blood; bioassay; kits; solid phase synthesis |
| 12/01/2004 | EP1480996A1 Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form |